Latest News - Miscellaneous

Thursday, February 23, 2017 | Miscellaneous, Calhoun Vision

Calhoun Vision Becomes RxSight

Calhoun Vision announced that it has formally changed its name to RxSight. The company also announced the filing of its initial premarket approval with the FDA as well as the addition of veteran healt…

Read the full story

Monday, February 20, 2017 | Miscellaneous

USC Roski Eye Institute Grows its Residency Program for First Time in More Than 30 Years

Based on exceptional clinical training opportunities and unprecedented engagement by its nationally-ranked faculty, the Accreditation Council for Graduate Medical Education (ACGME) approved the additi…

Read the full story

Wednesday, January 11, 2017 | Miscellaneous, Avedro

First US Service Members Treated with the Only FDA-Approved Cross-Linking Procedure in the US

Avedro has begun selling Photrexa Viscous (riboflavin 5-‘phosphate in 20% dextran ophthalmic solution), Photrexa (riboflavin 5’-phosphate ophthalmic solution) and the KXL System to key mil…

Read the full story

Thursday, December 29, 2016 | Miscellaneous

EyewireTV - 2016 Year in Review

There were several major industry announcements and advancements in ophthalmology in 2016. The top stories included the first FDA approval of a dry eye drug in the United States in more than a decade;…

Read the full story

Monday, December 26, 2016 | Miscellaneous, Aerie Pharmaceuticals

Aerie Pharmaceuticals Provides Update on Timing of NDA Filing for Rhopressa

Aerie Pharmaceuticals reported that it has been notified by its third party manufacturing vendor that the manufacturing line related to Rhopressa in their Tampa, Florida facility will not be ready for…

Read the full story

Wednesday, December 21, 2016 | Miscellaneous, Bausch+Lomb

Bausch + Lomb Shares New Letter to US Ophthalmologists

In a new letter to US ophthalmologists, Bausch + Lomb wrote: Dear Eye Care Professional: 2016 has been an exceptional year for Bausch + Lomb and the growth of our business as we have introduced …

Read the full story

Monday, December 19, 2016 | Miscellaneous

Lensar Files for Chapter 11 Bankruptcy; Announces Strategic Restructure

Lensar announced the filing of a Chapter 11 bankruptcy petition on December 19, 2016, to reduce its debt and strengthen its balance sheet and platform for growth, according to a company news rel…

Read the full story

Thursday, December 15, 2016 | Miscellaneous, Envision

Envision Raises a Record $446,000 at its Gala to Benefit Blind or Visually Impaired

Envision announced that its ninth annual "Evening with Envision: Phantom of the Opera Gala" raised $446,000 -- the most successful result in the event’s history. One hundred percent …

Read the full story

Wednesday, December 07, 2016 | Miscellaneous

AllAboutVision.com Launches Spanish Content

AllAboutVision.com has launched Spanish translations of some of the most popular articles in its Eye Conditions & Diseases section. In the United States, Spanish is the primary language spok…

Read the full story

Wednesday, November 23, 2016 | Miscellaneous, Alcon Laboratories

Alcon to Host Local Multifocal Contact Lens Fitting Event for Eye Care Professionals

Alcon will host a training event in Memphis, Tennessee later this month to help eye care professionals better fit multifocal contact lenses. This event will provide eye care professionals with tips an…

Read the full story

Monday, November 21, 2016 | Miscellaneous, Alcon Laboratories, Novartis

Novartis Backs Off From 2016 Date for Testing Google Autofocus Lens

Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google is "progressing steadil…

Read the full story

Monday, November 21, 2016 | Miscellaneous

Moorfields Eye Hospital Dubai Performs a Complex Eye Surgery to Remove Massive Orbital Tumor

Moorfields Eye Hospital Dubai, a branch of the Moorfields Eye Hospital in London, has successfully performed a highly complex surgical procedure in which a team removed a large tumor from behind a 26-…

Read the full story

Thursday, November 17, 2016 | Miscellaneous, Eyegate Pharmaceuticals

FDA Confirms a 510(k) De Novo Path for EyeGate's Ocular Bandage Gel

EyeGate Pharmaceuticals announced that, following a presubmission meeting with the FDA, it plans to pursue US regulatory clearance of its EyeGate Ocular Bandage Gel via the De Novo 510(k) pathway. Eye…

Read the full story

Thursday, November 17, 2016 | Miscellaneous, Valeant

Ex-Valeant Executive, Ex-Pharmacy CEO Charged for Fraud Scheme

US prosecutors on Thursday filed charges against a former Valeant Pharmaceuticals International executive and a former CEO of mail order pharmacy Philidor Rx Services, alleging they engaged in a multi…

Read the full story

Wednesday, November 09, 2016 | Miscellaneous, Bausch+Lomb, Nicox , Valeant

Nicox Provides Update on Latanoprostene Bunod and AC-170

Nicox SA provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170. Valeant Pharmaceuticals has stated that Nicox's licensee for latanoprostene bunod, Bau…

Read the full story
Load More